COUGH SYRUP

COUGH SYRUP was reported 388 times

COUGH SYRUP is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC TRAUMATIC ENCEPHALOPATHY 1 0.0714
1 VON WILLEBRAND'S DISEASE 1 0.0182
2 NOONAN SYNDROME 1 0.0175
3 ACCESSORY AURICLE 1 0.0143
4 BRONCHIAL INFECTION 1 0.0141
5 SEXUAL INHIBITION 1 0.0108
6 VENTRICLE RUPTURE 1 0.0074
7 ADMINISTRATION SITE IRRITATION 1 0.0071
8 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
9 CONGENITAL TRICUSPID VALVE ATRESIA 1 0.0067
10 GASTRITIS ATROPHIC 1 0.0066
11 NASAL ODOUR 1 0.0060
12 BLOOD IMMUNOGLOBULIN G ABNORMAL 1 0.0060
13 ADMINISTRATION SITE DISCOMFORT 1 0.0053
14 GRANULOCYTES ABNORMAL 1 0.0050
15 NAIL HYPERTROPHY 1 0.0049
16 NEONATAL PNEUMONIA 1 0.0043
17 HOARSENESS 2 0.0041
18 VENTRICULAR HYPOPLASIA 1 0.0040
19 CHOLESTEROSIS 1 0.0039
20 LOOSE STOOLS 1 0.0037
21 DERMATOPHYTOSIS 1 0.0035
22 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
23 MYOCARDIAL RUPTURE 1 0.0033
24 BED REST 1 0.0032
25 HEPATITIS ALCOHOLIC 1 0.0031
26 BASAL GANGLIA INFARCTION 1 0.0029
27 PANCREATOLITHIASIS 1 0.0025
28 PRIMARY BILIARY CHOLANGITIS 1 0.0021
29 METAPLASIA 1 0.0021
30 MARKEDLY REDUCED DIETARY INTAKE 1 0.0020
31 AUTOIMMUNE PANCREATITIS 1 0.0020
32 CERVICAL INCOMPETENCE 1 0.0020
33 PSYCHOTIC BEHAVIOUR 2 0.0020
34 DYSPNOEA EXACERBATED 1 0.0019
35 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
36 HAEMOGLOBINURIA 2 0.0018
37 GALLBLADDER NON-FUNCTIONING 1 0.0018
38 SINUS POLYP 1 0.0017
39 PROTRUSION TONGUE 1 0.0017
40 SJOGREN'S SYNDROME 1 0.0017
41 PNEUMONIA INFLUENZAL 2 0.0017
42 CYANOPSIA 1 0.0017
43 BODY HEIGHT BELOW NORMAL 1 0.0016
44 OBLITERATIVE BRONCHIOLITIS 2 0.0015
45 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
46 SPUTUM ABNORMAL 1 0.0015
47 ACCOMMODATION DISORDER 1 0.0014
48 PULMONARY ARTERY STENOSIS CONGENITAL 1 0.0014
49 ALLERGIC COUGH 1 0.0013
50 PNEUMONIA MYCOPLASMAL 1 0.0013
51 PULMONARY VALVE STENOSIS 1 0.0013
52 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0012
53 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
54 DENTAL DISCOMFORT 1 0.0012
55 ADRENAL SUPPRESSION 1 0.0012
56 BILIARY DYSKINESIA 2 0.0012
57 APTYALISM 1 0.0012
58 SKIN TEST POSITIVE 1 0.0011
59 HYPERMETROPIA 1 0.0011
60 HYPERVIGILANCE 1 0.0010
61 EYE COLOUR CHANGE 1 0.0010
62 BRAIN STEM INFARCTION 1 0.0010
63 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
64 NASAL INFLAMMATION 1 0.0009
65 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
66 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
67 LIGAMENT INJURY 1 0.0009
68 CHEMICAL BURN 1 0.0009
69 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
70 MUCOSAL HAEMORRHAGE 1 0.0009
71 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
72 CEREBRAL ARTERY EMBOLISM 1 0.0008
73 ACUTE PSYCHOSIS 2 0.0008
74 PALATAL OEDEMA 1 0.0008
75 FRACTURED COCCYX 1 0.0008
76 RADICULOPATHY 2 0.0008
77 ACROCHORDON 1 0.0008
78 OFF LABEL USE OF DEVICE 1 0.0007
79 NASAL DISCHARGE DISCOLOURATION 1 0.0007
80 PERITONEAL HAEMORRHAGE 1 0.0007
81 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
82 BILIARY COLIC 2 0.0007
83 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
84 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
85 RESPIRATORY RATE DECREASED 2 0.0006
86 MALIGNANT PLEURAL EFFUSION 1 0.0006
87 VOCAL CORD PARALYSIS 1 0.0006
88 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
89 OESOPHAGEAL SPASM 1 0.0005
90 HOMICIDE 1 0.0005
91 GASTRIC ULCER HAEMORRHAGE 3 0.0005
92 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
93 LOBAR PNEUMONIA 1 0.0005
94 PLASMACYTOMA 1 0.0005
95 PARANASAL SINUS DISCOMFORT 2 0.0005
96 MOTION SICKNESS 1 0.0005
97 ARTERIAL THROMBOSIS 1 0.0005
98 GALLBLADDER INJURY 1 0.0005
99 PYELONEPHRITIS ACUTE 1 0.0005
100 VOCAL CORD DISORDER 1 0.0005
101 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
102 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
103 DEVICE DEPOSIT ISSUE 1 0.0005
104 DRUG ABUSER 3 0.0005
105 MICROCYTIC ANAEMIA 1 0.0005
106 SPUTUM INCREASED 1 0.0005
107 PERIODONTITIS 1 0.0005
108 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
109 CHOLECYSTITIS CHRONIC 3 0.0004
110 CHRONIC GASTRITIS 1 0.0004
111 METASTASES TO MENINGES 1 0.0004
112 VARICELLA 1 0.0004
113 LEARNING DISORDER 1 0.0004
114 BLADDER DISORDER 4 0.0004
115 VENTRICULAR HYPERTROPHY 1 0.0004
116 LABYRINTHITIS 1 0.0004
117 PARKINSON'S DISEASE 1 0.0004
118 ABDOMINAL INFECTION 1 0.0004
119 RETINAL DISORDER 1 0.0004
120 URINE OUTPUT INCREASED 1 0.0004
121 MULTIPLE ALLERGIES 3 0.0004
122 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
123 BLOOD SODIUM INCREASED 1 0.0004
124 CLUMSINESS 1 0.0004
125 CHOLECYSTITIS INFECTIVE 1 0.0004
126 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
127 ENTEROCOLITIS 2 0.0003
128 HEPATITIS FULMINANT 1 0.0003
129 SCOLIOSIS 2 0.0003
130 SUBSTANCE USE DISORDER 1 0.0003
131 STUPOR 1 0.0003
132 OEDEMA MOUTH 1 0.0003
133 OTITIS MEDIA 1 0.0003
134 MENINGITIS 2 0.0003
135 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
136 BRONCHOPNEUMONIA 1 0.0003
137 REGURGITATION 1 0.0003
138 HAEMOPTYSIS 8 0.0003
139 EMBOLIC STROKE 1 0.0003
140 DUODENAL ULCER 2 0.0003
141 LUNG TRANSPLANT 1 0.0003
142 FRUSTRATION 1 0.0003
143 CAROTID ARTERY OCCLUSION 1 0.0003
144 ASTHMATIC CRISIS 1 0.0003
145 BLOOD PHOSPHORUS DECREASED 1 0.0003
146 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
147 SNORING 1 0.0003
148 CHEMOTHERAPY 1 0.0003
149 BOWEL MOVEMENT IRREGULARITY 2 0.0003
150 RENAL FAILURE CHRONIC 2 0.0003
151 PNEUMONIA FUNGAL 1 0.0003
152 POLYDIPSIA 1 0.0003
153 CANDIDIASIS 1 0.0002
154 ORGAN FAILURE 1 0.0002
155 RHINITIS 2 0.0002
156 VITAMIN B12 DEFICIENCY 1 0.0002
157 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
158 HOMICIDAL IDEATION 1 0.0002
159 HYPERAESTHESIA 2 0.0002
160 ATRIAL SEPTAL DEFECT 2 0.0002
161 AORTIC VALVE INCOMPETENCE 1 0.0002
162 PULMONARY TUBERCULOSIS 1 0.0002
163 ALCOHOLISM 1 0.0002
164 TENSION HEADACHE 1 0.0002
165 PULMONARY FUNCTION TEST DECREASED 1 0.0002
166 PARONYCHIA 1 0.0002
167 HAEMORRHAGIC ANAEMIA 1 0.0002
168 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
169 HAEMOGLOBIN INCREASED 1 0.0002
170 PERFORMANCE STATUS DECREASED 1 0.0002
171 CARDIAC TAMPONADE 1 0.0002
172 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
173 BRONCHOSPASM 3 0.0002
174 PRODUCTIVE COUGH 10 0.0002
175 NON-SMALL CELL LUNG CANCER 1 0.0002
176 HYPOVOLAEMIC SHOCK 1 0.0002
177 SUBCUTANEOUS ABSCESS 1 0.0002
178 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
179 BODY TEMPERATURE DECREASED 2 0.0002
180 BREATH SOUNDS ABNORMAL 1 0.0002
181 DIABETIC NEUROPATHY 1 0.0002
182 MULTIPLE DRUG OVERDOSE 1 0.0002
183 HEPATIC ENZYME ABNORMAL 1 0.0002
184 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
185 HYPOTHERMIA 2 0.0002
186 DRY THROAT 2 0.0002
187 SLUGGISHNESS 2 0.0002
188 INITIAL INSOMNIA 2 0.0002
189 INCREASED UPPER AIRWAY SECRETION 1 0.0002
190 TRISMUS 1 0.0002
191 PHARYNGOLARYNGEAL PAIN 1 0.0002
192 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
193 BRUXISM 1 0.0002
194 DECREASED ACTIVITY 2 0.0002
195 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
196 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
197 SKIN TOXICITY 1 0.0002
198 PREMATURE LABOUR 1 0.0002
199 CHOLECYSTITIS ACUTE 1 0.0002
200 PERONEAL NERVE PALSY 1 0.0002
201 BRONCHITIS 13 0.0002
202 VENTRICULAR SEPTAL DEFECT 1 0.0002
203 CAESAREAN SECTION 2 0.0002
204 ENERGY INCREASED 1 0.0002
205 SINUS HEADACHE 1 0.0002
206 PROTHROMBIN TIME PROLONGED 1 0.0002
207 HEARING IMPAIRED 1 0.0002
208 PLATELET COUNT ABNORMAL 1 0.0002
209 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
210 OLIGURIA 1 0.0002
211 ILEUS 2 0.0002
212 NASAL DRYNESS 1 0.0002
213 PHOTOPSIA 1 0.0002
214 SLEEP APNOEA SYNDROME 3 0.0002
215 PULMONARY FIBROSIS 3 0.0002
216 ENTERITIS 1 0.0002
217 PROCTALGIA 1 0.0002
218 CARDIAC FLUTTER 1 0.0002
219 ANGINA UNSTABLE 1 0.0002
220 INCORRECT PRODUCT STORAGE 2 0.0002
221 ORAL CANDIDIASIS 2 0.0002
222 PULMONARY CONGESTION 2 0.0002
223 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
224 CORONAVIRUS INFECTION 1 0.0002
225 SKIN MASS 1 0.0001
226 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
227 SINUS CONGESTION 2 0.0001
228 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
229 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
230 ECCHYMOSIS 1 0.0001
231 APHONIA 2 0.0001
232 PRODUCT SUPPLY ISSUE 1 0.0001
233 CARDIOGENIC SHOCK 2 0.0001
234 TONGUE DISORDER 1 0.0001
235 MOUTH HAEMORRHAGE 1 0.0001
236 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
237 FEELING DRUNK 1 0.0001
238 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
239 PAROSMIA 1 0.0001
240 COUGH 37 0.0001
241 PHARYNGEAL OEDEMA 2 0.0001
242 PERICARDIAL EFFUSION 3 0.0001
243 HAEMOLYSIS 1 0.0001
244 MUSCULOSKELETAL CHEST PAIN 2 0.0001
245 LUNG INFECTION 2 0.0001
246 DRUG SCREEN POSITIVE 1 0.0001
247 RENAL CYST 1 0.0001
248 RESPIRATORY TRACT CONGESTION 2 0.0001
249 NEUTROPENIA 17 0.0001
250 STENT PLACEMENT 1 0.0001
251 POLYURIA 1 0.0001
252 HAIR DISORDER 1 0.0001
253 NASAL CONGESTION 7 0.0001
254 DRUG USE DISORDER 1 0.0001
255 SENSATION OF FOREIGN BODY 1 0.0001
256 CANDIDA INFECTION 2 0.0001
257 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
258 HYPOPHAGIA 3 0.0001
259 URINE OUTPUT DECREASED 1 0.0001
260 BLOOD CALCIUM INCREASED 1 0.0001
261 SPINAL OSTEOARTHRITIS 1 0.0001
262 LUNG INFILTRATION 1 0.0001
263 EAR INFECTION 3 0.0001
264 RESPIRATORY RATE INCREASED 1 0.0001
265 PNEUMONITIS 3 0.0001
266 EXOSTOSIS 1 0.0001
267 INCREASED TENDENCY TO BRUISE 1 0.0001
268 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
269 UROSEPSIS 1 0.0001
270 IRON DEFICIENCY ANAEMIA 1 0.0001
271 OROPHARYNGEAL PAIN 10 0.0001
272 PRODUCT DISTRIBUTION ISSUE 1 0.0001
273 NEPHROPATHY 1 0.0001
274 LACERATION 1 0.0001
275 SPINAL DISORDER 1 0.0001
276 BLOOD URINE PRESENT 2 0.0001
277 PRODUCT PACKAGING ISSUE 1 0.0001
278 AFFECT LABILITY 1 0.0001
279 ATELECTASIS 1 0.0001
280 AUTOIMMUNE DISORDER 1 0.0001
281 ORAL HERPES 2 0.0001
282 RENAL TUBULAR NECROSIS 1 0.0001
283 THERAPY CHANGE 1 0.0001
284 LIGAMENT SPRAIN 1 0.0001
285 AGGRESSION 5 0.0001
286 POOR QUALITY DEVICE USED 1 0.0001
287 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
288 EMPHYSEMA 1 0.0001
289 TOOTH ABSCESS 1 0.0001
290 NEUTROPHIL COUNT INCREASED 1 0.0001
291 EUPHORIC MOOD 1 0.0001
292 SINUSITIS 10 0.0001
293 POOR VENOUS ACCESS 1 0.0001
294 PETECHIAE 1 0.0001
295 WEIGHT FLUCTUATION 1 0.0001
296 TRANSFUSION 1 0.0001
297 HALLUCINATION, VISUAL 2 0.0001
298 BREAST PAIN 1 0.0001
299 IRRITABLE BOWEL SYNDROME 2 0.0001
300 PHARYNGITIS STREPTOCOCCAL 1 0.0001
301 SEPTIC SHOCK 4 0.0001
302 DENTAL CARIES 1 0.0001
303 STEVENS-JOHNSON SYNDROME 2 0.0001
304 MALNUTRITION 1 0.0001
305 EYE INFECTION 1 0.0001
306 ASTHMA 10 0.0001
307 IMPAIRED DRIVING ABILITY 1 0.0001
308 DERMATITIS CONTACT 1 0.0001
309 GASTRIC HAEMORRHAGE 1 0.0001
310 DRY MOUTH 7 0.0001
311 MADAROSIS 1 0.0001
312 DYSPHONIA 5 0.0001
313 SEXUAL DYSFUNCTION 1 0.0001
314 BLOOD IRON DECREASED 1 0.0001
315 CHOLECYSTITIS 1 0.0001
316 HYPERLIPIDAEMIA 1 0.0001
317 POLYNEUROPATHY 1 0.0001
318 NOCTURIA 1 0.0001
319 NO THERAPEUTIC RESPONSE 1 0.0001
320 CEREBRAL INFARCTION 2 0.0001
321 CARDIOMEGALY 1 0.0001
322 INJECTION SITE EXTRAVASATION 1 0.0001
323 GENERALISED OEDEMA 1 0.0001
324 HAIR COLOUR CHANGES 1 0.0001
325 TOOTH EXTRACTION 1 0.0001
326 PEMPHIGUS 1 0.0001
327 DYSARTHRIA 3 0.0001
328 COLITIS 3 0.0001
329 MUSCLE ATROPHY 1 0.0001
330 MYDRIASIS 1 0.0001
331 ANOREXIA 1 0.0001
332 PNEUMONIA 25 0.0001
333 DIPLOPIA 2 0.0001
334 ANHEDONIA 2 0.0001
335 TOOTH INFECTION 1 0.0001
336 DISORIENTATION 3 0.0001
337 HAIR TEXTURE ABNORMAL 1 0.0001
338 QUALITY OF LIFE DECREASED 1 0.0001
339 FEAR 2 0.0001
340 PAIN OF SKIN 2 0.0001
341 PRODUCT TASTE ABNORMAL 1 0.0001
342 PULMONARY EMBOLISM 7 0.0001
343 TACHYPNOEA 1 0.0001
344 PALLOR 2 0.0001
345 DRUG TOXICITY 1 0.0001
346 AKATHISIA 1 0.0001
347 OSTEOPOROSIS 3 0.0001
348 CORONARY ARTERY OCCLUSION 1 0.0001
349 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
350 APPLICATION SITE RASH 1 0.0001
351 RESPIRATORY ARREST 2 0.0001
352 ORAL DISCOMFORT 1 0.0001
353 COORDINATION ABNORMAL 1 0.0001
354 DEMENTIA 2 0.0001
355 DEVICE OCCLUSION 1 0.0001
356 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
357 TARDIVE DYSKINESIA 2 0.0001
358 HYPERSOMNIA 2 0.0001
359 ANOSMIA 1 0.0001
360 INJECTION SITE HAEMATOMA 1 0.0001
361 RESPIRATORY FAILURE 5 0.0001
362 GASTROENTERITIS 1 0.0001
363 URINARY INCONTINENCE 2 0.0001
364 THROAT IRRITATION 3 0.0001
365 PREMATURE BABY 2 0.0001
366 PRODUCT QUALITY ISSUE 9 0.0001
367 ECONOMIC PROBLEM 1 0.0001
368 DEVICE FAILURE 1 0.0001
369 INSURANCE ISSUE 1 0.0001
370 LIMB DISCOMFORT 2 0.0001
371 SOMNOLENCE 13 0.0001
372 ACUTE MYELOID LEUKAEMIA 1 0.0001
373 THERAPY PARTIAL RESPONDER 1 0.0001
374 NERVOUS SYSTEM DISORDER 2 0.0001
375 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
376 PNEUMOTHORAX 1 0.0001
377 HALLUCINATION, AUDITORY 1 0.0001
378 OBESITY 1 0.0001
379 SCIATICA 1 0.0001
380 SENSORY DISTURBANCE 1 0.0001
381 RHINORRHOEA 4 0.0001
382 MUSCLE TIGHTNESS 1 0.0001
383 LUNG DISORDER 3 0.0001
384 CHOLELITHIASIS 2 0.0001
385 MANIA 1 0.0001
386 VENTRICULAR TACHYCARDIA 1 0.0001
387 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
388 FEBRILE NEUTROPENIA 4 0.0001
389 BLOOD PRESSURE DECREASED 4 0.0001
390 VIRAL INFECTION 2 0.0001
391 COAGULOPATHY 1 0.0001
392 NASOPHARYNGITIS 11 0.0001
393 TYPE 2 DIABETES MELLITUS 2 0.0001
394 HYPERKALAEMIA 2 0.0001
395 AMENORRHOEA 1 0.0001
396 HEART RATE DECREASED 2 0.0001
397 INJURY 4 0.0001
398 COLD SWEAT 1 0.0001
399 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
400 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
401 GALLBLADDER DISORDER 1 0.0001
402 GOUT 1 0.0001
403 LEUKOCYTOSIS 1 0.0001
404 RESTLESS LEGS SYNDROME 1 0.0001
405 END STAGE RENAL DISEASE 1 0.0001
406 AGITATION 4 0.0001
407 BLOOD GLUCOSE ABNORMAL 1 0.0001
408 MEDICATION ERROR 3 0.0001
409 MIDDLE INSOMNIA 1 0.0001
410 EPISTAXIS 4 0.0001
411 OXYGEN SATURATION DECREASED 3 0.0001
412 PHOTOPHOBIA 1 0.0001
413 DYSPNOEA EXERTIONAL 2 0.0001
414 HALLUCINATION 4 0.0001
415 INCREASED APPETITE 1 0.0001
416 EYE IRRITATION 3 0.0001
417 POST PROCEDURAL COMPLICATION 1 0.0001
418 ACUTE RESPIRATORY FAILURE 1 0.0001
419 HERNIA 1 0.0001
420 ERUCTATION 1 0.0001
421 PRESCRIBED OVERDOSE 1 0.0001
422 EAR PAIN 1 0.0001
423 CHOKING 1 0.0001
424 DRUG DOSE OMISSION BY DEVICE 4 0.0001
425 DISABILITY 1 0.0001
426 HEART RATE INCREASED 5 0.0001
427 HAEMATOCRIT DECREASED 1 0.0001
428 CATARACT 3 0.0001
429 BLOOD PRESSURE ABNORMAL 1 0.0001
430 UPPER LIMB FRACTURE 1 0.0001
431 HYPOTENSION 10 0.0000
432 PLEURAL EFFUSION 3 0.0000
433 NEUTROPHIL COUNT DECREASED 2 0.0000
434 BODY TEMPERATURE INCREASED 1 0.0000
435 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
436 LUNG NEOPLASM MALIGNANT 2 0.0000
437 TREMOR 8 0.0000
438 PULMONARY HYPERTENSION 1 0.0000
439 ROAD TRAFFIC ACCIDENT 2 0.0000
440 ABDOMINAL PAIN 11 0.0000
441 RETCHING 1 0.0000
442 IMPAIRED WORK ABILITY 1 0.0000
443 POOR QUALITY SLEEP 1 0.0000
444 FAECES DISCOLOURED 1 0.0000
445 AMNESIA 3 0.0000
446 VAGINAL HAEMORRHAGE 2 0.0000
447 FEELING ABNORMAL 11 0.0000
448 MELAENA 1 0.0000
449 TACHYCARDIA 4 0.0000
450 TRANSAMINASES INCREASED 1 0.0000
451 INFLUENZA 5 0.0000
452 VOMITING 21 0.0000
453 ORAL PAIN 1 0.0000
454 RASH PAPULAR 1 0.0000
455 SNEEZING 1 0.0000
456 APPLICATION SITE PRURITUS 1 0.0000
457 DEPRESSION 10 0.0000
458 PRODUCT AVAILABILITY ISSUE 1 0.0000
459 HYPOKALAEMIA 2 0.0000
460 DYSPNOEA 24 0.0000
461 ARRHYTHMIA 2 0.0000
462 ANXIETY 12 0.0000
463 COMA 2 0.0000
464 RASH ERYTHEMATOUS 2 0.0000
465 BLOOD GLUCOSE DECREASED 2 0.0000
466 INSOMNIA 11 0.0000
467 MENTAL IMPAIRMENT 1 0.0000
468 INJECTION SITE URTICARIA 1 0.0000
469 ABASIA 1 0.0000
470 PYREXIA 14 0.0000
471 EXTRAPYRAMIDAL DISORDER 1 0.0000
472 LEUKOPENIA 2 0.0000
473 CELLULITIS 2 0.0000
474 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
475 DIABETES MELLITUS 3 0.0000
476 FLUSHING 4 0.0000
477 HEPATITIS 1 0.0000
478 ERECTILE DYSFUNCTION 1 0.0000
479 DECREASED APPETITE 9 0.0000
480 UNRESPONSIVE TO STIMULI 1 0.0000
481 SKIN ULCER 1 0.0000
482 NO ADVERSE EVENT 7 0.0000
483 RESPIRATORY TRACT INFECTION 1 0.0000
484 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
485 NERVOUSNESS 2 0.0000
486 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
487 PARAESTHESIA 6 0.0000
488 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
489 THROMBOSIS 3 0.0000
490 BLOOD BILIRUBIN INCREASED 1 0.0000
491 THROAT TIGHTNESS 1 0.0000
492 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
493 OEDEMA 2 0.0000
494 MOOD ALTERED 1 0.0000
495 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
496 ABNORMAL DREAMS 1 0.0000
497 DIZZINESS 18 0.0000
498 FEELING COLD 1 0.0000
499 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
500 WEIGHT DECREASED 10 0.0000
501 PANCYTOPENIA 2 0.0000
502 HYPONATRAEMIA 2 0.0000
503 FLATULENCE 2 0.0000
504 MUSCULAR WEAKNESS 4 0.0000
505 RED BLOOD CELL COUNT DECREASED 1 0.0000
506 CONVULSION 2 0.0000
507 ASTHENIA 13 0.0000
508 ASCITES 1 0.0000
509 WHEEZING 2 0.0000
510 RENAL INJURY 1 0.0000
511 RESPIRATORY DISORDER 1 0.0000
512 IRRITABILITY 2 0.0000
513 LACRIMATION INCREASED 1 0.0000
514 THERAPEUTIC RESPONSE DECREASED 2 0.0000
515 STOMATITIS 2 0.0000
516 ILL-DEFINED DISORDER 2 0.0000
517 EPILEPSY 1 0.0000
518 DRUG ADMINISTRATION ERROR 1 0.0000
519 EMOTIONAL DISORDER 1 0.0000
520 CHEST PAIN 6 0.0000
521 CONSTIPATION 7 0.0000
522 SWOLLEN TONGUE 1 0.0000
523 DRUG-INDUCED LIVER INJURY 1 0.0000
524 BLOOD GLUCOSE INCREASED 6 0.0000
525 DYSPHAGIA 3 0.0000
526 HYPOTHYROIDISM 1 0.0000
527 INTENTIONAL OVERDOSE 2 0.0000
528 MOVEMENT DISORDER 1 0.0000
529 DRUG DEPENDENCE 5 0.0000
530 CONFUSIONAL STATE 5 0.0000
531 LACTIC ACIDOSIS 1 0.0000
532 DEEP VEIN THROMBOSIS 2 0.0000
533 EYE DISORDER 1 0.0000
534 HEADACHE 19 0.0000
535 VISUAL ACUITY REDUCED 1 0.0000
536 FUNGAL INFECTION 1 0.0000
537 DEHYDRATION 4 0.0000
538 SYNCOPE 3 0.0000
539 EYE PRURITUS 1 0.0000
540 URINARY TRACT INFECTION 5 0.0000
541 CHEST DISCOMFORT 3 0.0000
542 HAEMOGLOBIN DECREASED 3 0.0000
543 HAEMATURIA 1 0.0000
544 GASTRIC DISORDER 1 0.0000
545 VISION BLURRED 4 0.0000
546 MEMORY IMPAIRMENT 4 0.0000
547 NIGHTMARE 1 0.0000
548 NEOPLASM PROGRESSION 1 0.0000
549 HAEMORRHAGE 3 0.0000
550 MYOCARDIAL INFARCTION 5 0.0000
551 BURNING SENSATION 2 0.0000
552 DEVICE MALFUNCTION 2 0.0000
553 HYPOXIA 1 0.0000
554 SLEEP DISORDER 2 0.0000
555 LYMPHADENOPATHY 1 0.0000
556 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
557 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
558 CEREBRAL HAEMORRHAGE 1 0.0000
559 SKIN BURNING SENSATION 2 0.0000
560 OVERDOSE 6 0.0000
561 HYPERGLYCAEMIA 1 0.0000
562 PANIC ATTACK 1 0.0000
563 RESTLESSNESS 1 0.0000
564 DYSURIA 1 0.0000
565 CHRONIC KIDNEY DISEASE 2 0.0000
566 ANAEMIA 5 0.0000
567 BLOOD PRESSURE INCREASED 4 0.0000
568 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
569 PRURITUS 10 0.0000
570 PLASMA CELL MYELOMA 1 0.0000
571 ARTHRITIS 2 0.0000
572 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
573 NAUSEA 20 0.0000
574 ABNORMAL BEHAVIOUR 1 0.0000
575 INJECTION SITE HAEMORRHAGE 2 0.0000
576 CARDIAC FAILURE CONGESTIVE 2 0.0000
577 EMOTIONAL DISTRESS 3 0.0000
578 OEDEMA PERIPHERAL 3 0.0000
579 DYSKINESIA 1 0.0000
580 PAIN 15 0.0000
581 FATIGUE 19 0.0000
582 INFLUENZA LIKE ILLNESS 2 0.0000
583 CARDIAC ARREST 2 0.0000
584 DRUG DOSE OMISSION 4 0.0000
585 POLLAKIURIA 1 0.0000
586 CARDIO-RESPIRATORY ARREST 1 0.0000
587 RENAL IMPAIRMENT 2 0.0000
588 CEREBROVASCULAR ACCIDENT 4 0.0000
589 MYALGIA 4 0.0000
590 LOSS OF CONSCIOUSNESS 3 0.0000
591 BALANCE DISORDER 2 0.0000
592 DEVICE LEAKAGE 1 0.0000
593 COVID-19 4 0.0000
594 DRUG WITHDRAWAL SYNDROME 2 0.0000
595 RENAL FAILURE 3 0.0000
596 PULMONARY OEDEMA 1 0.0000
597 WEIGHT INCREASED 5 0.0000
598 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
599 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
600 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
601 SUICIDAL IDEATION 2 0.0000
602 TINNITUS 1 0.0000
603 SKIN DISCOLOURATION 1 0.0000
604 ADVERSE EVENT 2 0.0000
605 DIARRHOEA 14 0.0000
606 BLOOD CHOLESTEROL INCREASED 1 0.0000
607 OCULAR HYPERAEMIA 1 0.0000
608 DISEASE RECURRENCE 1 0.0000
609 MIGRAINE 2 0.0000
610 CONTUSION 2 0.0000
611 INTERSTITIAL LUNG DISEASE 1 0.0000
612 HYPOGLYCAEMIA 1 0.0000
613 MALAISE 9 0.0000
614 PAIN IN EXTREMITY 6 0.0000
615 DYSPEPSIA 2 0.0000
616 DRY EYE 1 0.0000
617 FLUID RETENTION 1 0.0000
618 ACUTE KIDNEY INJURY 3 0.0000
619 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
620 ERYTHEMA 4 0.0000
621 ILLNESS 2 0.0000
622 ABDOMINAL DISTENSION 2 0.0000
623 MUSCULOSKELETAL PAIN 1 0.0000
624 SPEECH DISORDER 1 0.0000
625 BRADYCARDIA 1 0.0000
626 PLATELET COUNT DECREASED 2 0.0000
627 DISTURBANCE IN ATTENTION 1 0.0000
628 RASH PRURITIC 1 0.0000
629 RASH 8 0.0000
630 ANAPHYLACTIC REACTION 1 0.0000
631 ARTHROPATHY 1 0.0000
632 URTICARIA 3 0.0000
633 NECK PAIN 1 0.0000
634 ABDOMINAL DISCOMFORT 3 0.0000
635 THROMBOCYTOPENIA 2 0.0000
636 TOXICITY TO VARIOUS AGENTS 3 0.0000
637 LETHARGY 1 0.0000
638 PRODUCT SUBSTITUTION ISSUE 1 0.0000
639 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
640 PALPITATIONS 2 0.0000
641 BONE PAIN 1 0.0000
642 SUICIDE ATTEMPT 1 0.0000
643 VERTIGO 1 0.0000
644 MUSCLE SPASMS 3 0.0000
645 FEELING HOT 1 0.0000
646 HYPERSENSITIVITY 3 0.0000
647 INJECTION SITE ERYTHEMA 2 0.0000
648 PRODUCT USE ISSUE 3 0.0000
649 DRUG INEFFECTIVE 21 0.0000
650 GAIT DISTURBANCE 3 0.0000
651 SWELLING FACE 1 0.0000
652 PRODUCT DOSE OMISSION 1 0.0000
653 NEOPLASM MALIGNANT 1 0.0000
654 UNDERDOSE 1 0.0000
655 DYSGEUSIA 1 0.0000
656 HOT FLUSH 1 0.0000
657 UNEVALUABLE EVENT 1 0.0000
658 ACNE 1 0.0000
659 INJECTION SITE SWELLING 1 0.0000
660 BACK PAIN 3 0.0000
661 DRUG INTERACTION 2 0.0000
662 CARDIAC FAILURE 1 0.0000
663 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
664 DRUG ABUSE 1 0.0000
665 INTENTIONAL PRODUCT MISUSE 1 0.0000
666 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
667 MUSCULOSKELETAL STIFFNESS 1 0.0000
668 ADVERSE DRUG REACTION 1 0.0000
669 CARDIAC DISORDER 1 0.0000
670 SWELLING 1 0.0000
671 NEUROPATHY PERIPHERAL 1 0.0000
672 ATRIAL FIBRILLATION 1 0.0000
673 CONDITION AGGRAVATED 3 0.0000
674 ABDOMINAL PAIN UPPER 2 0.0000
675 ARTHRALGIA 4 0.0000
676 HYPERTENSION 2 0.0000
677 FALL 3 0.0000
678 SEPSIS 1 0.0000
679 RHEUMATOID ARTHRITIS 1 0.0000
680 INCORRECT DOSE ADMINISTERED 2 0.0000
681 SEIZURE 1 0.0000
682 DEATH 7 0.0000
683 OFF LABEL USE 7 0.0000
684 HYPERHIDROSIS 1 0.0000
685 INFECTION 1 0.0000
686 PRODUCT DOSE OMISSION ISSUE 2 0.0000
687 HYPOAESTHESIA 1 0.0000
688 INJECTION SITE PAIN 2 0.0000
689 HOSPITALISATION 1 0.0000
690 ALOPECIA 1 0.0000
691 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000